Back

Rational use of natriuretic peptide testing in primary care - an observational study from a Danish regional hospital

11 May 2024 (09:00 - 10:20)
Organised by: Logo
Congress Presentation Part of: ePosters in chronic heart failure - biomarkers 1 Biomarkers HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speakers

Photo
Doctor Louise Lylloff

Goedstrup Hospital, Herning (Denmark)

Photo
Associate Professor Nete Hornung

Goedstrup Hospital, Herning (Denmark)

5 More presentations in this session

Presentation thumbnail
Sacubitril/valsartan and cardiovascular biomarkers among patients with recent COVID-19 infection: the PARACOR-19 randomized clinical trial
Doctor S. Greene (Durham, US)
Abstract Slides Video
Presentation thumbnail
Correlation of NT-proBNP and residual ischemic risk in patients with heart failure and myocardial revascularization.
Mrs J. Cazacu (Chisinau, MD)
Abstract Slides Video
Presentation thumbnail
CA125 assessment using ABEI-based assay in heart failure: implications for disease severity and cardiac biomarkers
Professor D. Gruson (Brussels, BE)
Abstract Slides Video
Presentation thumbnail
The relationship of natriuretic peptides and body mass index in chronic heart failure, a systematic review
Professor C. Ross (Belfast, GB)
Abstract Slides Video
Presentation thumbnail
QRS complex duration and type conduction disturbances as a simple predictor of left ventricle remodelation in patients with recent onset of dilated cardiomyopathy?
Professor R. Pudil (Prague, CZ)
Abstract Slides Video

Access the full session

Session thumbnail
ePosters in chronic heart failure - biomarkers 1

The Event

Event poster

Heart Failure 2024

11 May 2024 09:00 CET
You may be interested in
thumbnail
Congress Presentation
Does change in natriuretic peptide indicate clinically meaningful change in heart failure status in stable heart failure?
thumbnail
Congress Presentation
Early increase and subsequent decrease in mature BNP and early decrease and continued decrease in proBNP after sacubitril/valsartan may relate to left ventricular reverse remodeling in heart failure
thumbnail
Congress Presentation
Improvement of biomarkers is associated with improved patient quality-of-life measures after heart failure hospitalisation: a sub-study of the Medly-AID randomised controlled trial

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources